Skip to content

K-Stock Briefing

https://kstockbriefing.com

  • About Us
  • News
    • News
  • IR Room
  • RESEARCH
  • Disclosures
    • Semiconductors
    • Bio & Healthcare
    • Defense
    • Shipbuilding
  • Toggle search form

[Disclosure] Celltrion (068270) to List Amending Shares Following Retirement of 1.10 Million Common Shares on April 7, 2025

Posted on April 2, 2025July 15, 2026 By K-STOCK Editor No Comments on [Disclosure] Celltrion (068270) to List Amending Shares Following Retirement of 1.10 Million Common Shares on April 7, 2025

Source of Fact: Financial Supervisory Service DART / 2025-04-02

Disclosure Type: Listing of Amending Shares (Retirement of Shares)

💡 3-Second Summary

Following the execution of a share retirement, Celltrion’s total outstanding common shares will decrease by 1,101,379 shares, and the corresponding amended listing is scheduled for April 7, 2025.

📊 1. [Key Disclosure Content & Major Figures Summary]

Celltrion officially disclosed the schedule for the amended listing of common shares following the share retirement as follows:

  • Listed Issue: Celltrion Common Stock
  • Type and Number of Shares (Before Change → After Change): Registered common shares 214,108,119 shares → 213,006,740 shares (154th issuance)
  • Change in Number of Shares (Decreased Shares): -1,101,379 shares
  • Par Value per Share: KRW 1,000
  • Date of Issuance (Retirement Date): March 25, 2025
  • Dividend Accrual Date: January 1, 2025 (Fiscal year-end: Last day of December)
  • Amended Listing Date: April 7, 2025
  • Reason for Change: Retirement of shares
  • Identification Codes: Short Code 068270 (Standard Code KR7068270008, Industry Code 03-21-01)

📈 2. [Expert’s Perspective: What This Disclosure Means for Investors]

This filing outlines the timeline for the amended listing to register the outcome of the previously executed share retirement (Retirement Date: March 25, 2025) on the stock exchange. According to the data provided in the disclosure, the total outstanding registered common shares of Celltrion will be reduced from 214,108,119 shares to 213,006,740 shares, resulting in a decrease of 1,101,379 shares.

Investors can identify that the administrative date on which the reduced share count officially takes effect on the market is April 7, 2025. As this disclosure only reports the completion of the administrative steps of the retirement and does not provide direct explanations regarding stock price changes or financial adjustments, investors should note the scheduled date as an objective fact.

📝 Editor’s Comment (by K-STOCK Editor)

This disclosure details the decrease in the total outstanding share count and the amended listing schedule following the execution of a share retirement. The retirement itself was completed on the retirement date of March 25, and this amended listing on April 7 officially registers the updated numbers on the exchange, concluding the administrative process.

The primary checkpoint for investors moving forward is to verify whether the reduction in the outstanding share count is successfully updated as planned on April 7, 2025. The filing does not mention any specific shifts in individual shareholder ownership ratios or the resulting impact on detailed financial ratios, so any external assumptions should be avoided.

Accordingly, investors should continue to track whether this share retirement is consistently reflected under the ‘Changes in Share Capital’ and ‘Total Number of Issued Shares’ sections in the upcoming quarterly reports.

📢 Disclaimer & Source Information

Source: This content was structured and newly generated based on official data submitted to the Financial Supervisory Service’s DART system.

Investment Risk Advisory: This content is provided solely for informational and linguistic reference purposes. Under no circumstances does it constitute financial advice or a recommendation to buy or sell any specific stock. All investment decisions and financial responsibilities rest entirely with the individual investor.

Inquiries: For compliance-related inquiries or copyright requests, please contact us at ksb220805@gmail.com.

🐂
BULLS
VS
🐻
BEARS

🔥 Bulls vs Bears, drop your analysis in the comments!

Disclosures, Bio & Healthcare

Post navigation

Previous Post: [Disclosure] HANMI Semiconductor (042700) Designated as Short-Selling Overheated Stock Again: Heavy Short Attacks Trigger Trading Ban on April 3
Next Post: [Disclosure] Celltrion (068270) Decides to Retire Treasury Shares Worth Approx. KRW 45.2 Billion

Related Posts

[Disclosure] Samsung Biologics (207940) Announces AGM Results… Financial Statements Approved with KRW 4.5T Revenue and KRW 2T Operating Profit Disclosures
[Disclosure] JUSUNG ENGINEERING (036930) Swings to Black in Q2 with KRW 36B Operating Profit… Explosive Turnaround Rising +413% QoQ Semiconductors
[Disclosure] Hanwha Ocean (042660) Formally Approves KRW 236.1B Debt-to-Equity Swap for Singapore Affiliate Disclosures
[Disclosure] Alteogen(196170) Changes CEO from Soon Jae Park to Tae Yeon Jeon Disclosures
[Disclosure] Samsung Electronics (005930) Re-lists Overseas DR Preferred Shares onto London Stock Exchange; Relocating from Luxembourg to Maximize Trading Liquidity Semiconductors
[Disclosure] Hanwha Ocean (042660) Signs KRW 1.24T ‘4 LNG Carriers’ Construction Contract with Asian Shipowner Disclosures

Leave a Reply Cancel reply

You must be logged in to post a comment.

  • [Disclosure] Alteogen (196170) Establishes August 6 as Record Date for Bonus Issue Share AllotmentJuly 16, 2026
  • [Disclosure] Alteogen (196170) Announces Trading Suspension and Resumption Schedule for Stock Futures and OptionsJuly 16, 2026
  • [Disclosure] Alteogen (196170) Temporarily Suspends Plans for Relisting on the KOSPI MarketJuly 16, 2026
  • [Disclosure] Alteogen (196170) Announces Temporary Trading Suspension on July 16 Due to Bonus Issue DecisionJuly 16, 2026
  • [Disclosure] Alteogen (196170) Decides on Bonus Issue of 0.3 Shares per 1 Common and Preferred ShareJuly 16, 2026

Copyright © 2026 K-Stock Briefing.

Powered by PressBook Grid Dark theme